|
1
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yiwei T, Hua H, Hui G, Mao M and Xiang L:
HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell
proliferation, migration, and invasion. Med Sci Monit.
21:1856–1863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
ENCODE Project Consortium; Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J,
Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA
AK001796 acts as an oncogene and is involved in cell growth
inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol.
285:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X,
Zhang W, Deng H, Zhou M, Peng S, et al: AFAP1-AS1, a long noncoding
RNA upregulated in lung cancer and promotes invasion and
metastasis. Tumour Biol. 37:729–737. 2016. View Article : Google Scholar
|
|
11
|
Qiu JJ, Wang Y, Ding JX, Jin HY, Yang G
and Hua KQ: The long non-coding RNA HOTAIR promotes the
proliferation of serous ovarian cancer cells through the regulation
of cell cycle arrest and apoptosis. Exp Cell Res. 333:238–248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ono H, Motoi N, Nagano H, Miyauchi E,
Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N and
Ishikawa Y: Long noncoding RNA HOTAIR is relevant to cellular
proliferation, invasiveness, and clinical relapse in small-cell
lung cancer. Cancer Med. 3:632–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han Y, Liu Y, Zhang H, Wang T, Diao R,
Jiang Z, Gui Y and Cai Z: Hsa-miR-125b suppresses bladder cancer
development by down-regulating oncogene SIRT7 and oncogenic long
noncoding RNA MALAT1. FEBS Lett. 587:3875–3882. 2013. View Article : Google Scholar
|
|
14
|
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y,
Zhao L, Zhang Y, Huang B and Lu J: LincRNA-ROR induces
epithelial-to-mesenchymal transition and contributes to breast
cancer tumorigenesis and metastasis. Cell Death Dis. 5:e12872014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W and Chen Jf: Long noncoding RNA
ANRIL indicates a poor prognosis of gastric cancer and promotes
tumor growth by epigenetically silencing of miR-99a/miR-449a.
Oncotarget. 5:2276–2292. 2014. View Article : Google Scholar :
|
|
16
|
Xia T, Chen S, Jiang Z, Shao Y, Jiang X,
Li P, Xiao B and Guo J: Long noncoding RNA FER1L4 suppresses cancer
cell growth by acting as a competing endogenous RNA and regulating
PTEN expression. Sci Rep. 5:134452015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW,
Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding
RNA HOTAIR predicts poor patient prognosis and promotes tumor
metastasis in epithelial ovarian cancer. Gynecol Oncol.
134:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al:
A functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao
T, Liu Y, Ou J, Wang D, Yao L, et al: LncRNA-HOST2 regulates cell
biological behaviors in epithelial ovarian cancer through a
mechanism involving microRNA let-7b. Hum Mol Genet. 24:841–852.
2015. View Article : Google Scholar
|
|
20
|
Li J, Zhou D, Wang Z, Tan L, Zhou Y, Li J
and Sheng X: Reversal effect of 5-aza-2-deoxycytidine on the
maternally expressed gene 3 promoter hypermethylation and its
inhibitory effect on the proliferation of epithelial ovarian cancer
cells. Zhonghua Zhong Liu Za Zhi. 37:324–329. 2015.In Chinese.
PubMed/NCBI
|
|
21
|
Yang Y, Jiang Y, Wan Y, Zhang L, Qiu J,
Zhou S and Cheng W: UCA1 functions as a competing endogenous RNA to
suppress epithelial ovarian cancer metastasis. Tumour Biol.
37:10633–10641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
The Gene Ontology Consortium: Expansion of
the Gene Ontology knowledgebase and resources. Nucleic Acids Res.
45(D1): D331–D338. 2017. View Article : Google Scholar :
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
26
|
Darryl N: Biotech Software & Internet
Report 2. 117–120. 2004.
|
|
27
|
Fabregat A, Jupe S, Matthews L,
Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger
F, May B, et al: The reactome pathway knowledgebase. Nucleic Acids
Res. 46(D1): D649–D655. 2018. View Article : Google Scholar :
|
|
28
|
Milacic M, Haw R, Rothfels K, Wu G, Croft
D, Hermjakob H, D'Eustachio P and Stein L: Annotating cancer
variants and anti-cancer therapeutics in reactome. Cancers (Basel).
4:1180–1211. 2012. View Article : Google Scholar
|
|
29
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao G, Zhang J, Wang M, Song X, Liu W, Mao
C and Lv C: Differential expression of long non-coding RNAs in
bleomycin-induced lung fibrosis. Int J Mol Med. 32:355-3642013.
View Article : Google Scholar
|
|
31
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cohen M, Pierredon S, Wuillemin C, Delie F
and Petignat P: Acellular fraction of ovarian cancer ascites induce
apoptosis by activating JNK and inducing BRCA1, Fas and FasL
expression in ovarian cancer cells. Oncoscience. 1:262–271. 2014.
View Article : Google Scholar
|
|
33
|
Hayano T, Yokota Y, Hosomichi K, Nakaoka
H, Yoshihara K, Adachi S, Kashima K, Tsuda H, Moriya T, Tanaka K,
et al: Molecular characterization of an intact p53 pathway subtype
in high-grade serous ovarian cancer. PLoS One. 9:e1144912014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Hu K, Gong G, Zhu D, Wang Y, Liu H
and Wu X: Upregulation of MiR-205 transcriptionally suppresses
SMAD4 and PTEN and contributes to human ovarian cancer progression.
Sci Rep. 7:413302017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bugide S, Gonugunta VK, Penugurti V,
Malisetty VL, Vadlamudi RK and Manavathi B: HPIP promotes
epithelial-mesenchymal transition and cisplatin resistance in
ovarian cancer cells through PI3K/AKT pathway activation. Cell
Oncol (Dordr). 40:133–144. 2017. View Article : Google Scholar
|
|
36
|
Zeppernick F and Meinhold-Heerlein I: The
new FIGO staging system for ovarian, fallopian tube, and primary
peritoneal cancer. Arch Gynecol Obstet. 290:839–842. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jelovac D: Armstrong DK. Recent progress
in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin.
61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1
promotes tumour growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP2 from SFPQ/TBP2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi Y, Liu Y, Wang J, Jie D, Yun T, Li W,
Yan L, Wang K and Feng J: Downregulated long noncoding RNA BANCR
promotes the proliferation of colorectal cancer cells via
downregualtion of p21 expression. PLoS One. 10:e01226792015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xue M, Li X, Li Z and Chen W: Urothelial
carcinoma associated 1 is a hypoxia-inducible
factor-1alpha-targeted long noncoding RNA that enhances hypoxic
bladder cancer cell proliferation, migration, and invasion. Tumour
Biol. 35:6901–6912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Srivastava AK, Singh PK, Rath SK, Dalela
D, Goel MM and Bhatt ML: Appraisal of diagnostic ability of UCA1 as
a biomarker of carcinoma of the urinary bladder. Tumour Biol.
35:11435–11442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y,
Zhang W, Jing T, Zhang C, Shen J, et al: Development and
prospective multicenter evaluation of the long noncoding RNA
MALAT-1 as a diagnostic urinary biomarker for prostate cancer.
Oncotarget. 5:11091–11102. 2014.PubMed/NCBI
|
|
43
|
Yin D, He X, Zhang E, Kong R, De W and
Zhang Z: Long noncoding RNA GAS5 affects cell proliferation and
predicts a poor prognosis in patients with colorectal cancer. Med
Oncol. 31:2532014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li H, Li J, Jia S, Wu M, An J, Zheng Q,
Zhang W and Lu D: miR675 upregulates long noncoding RNA H19 through
activating EGR1 in human liver cancer. Oncotarget. 6:31958–31984.
2015.PubMed/NCBI
|
|
46
|
Qu S, Yang X, Song W, Sun W, Li X, Wang J,
Zhong Y, Shang R, Ruan B, Zhang Z, et al: Downregulation of
lncRNA-ATB correlates with clinical progression and unfavorable
prognosis in pancreatic cancer. Tumour Biol. 37:3933–3938. 2016.
View Article : Google Scholar
|
|
47
|
Zhou J, Li W, Jin T, Xiang X, Li M, Wang
J, Li G, Pan X and Lei D: Gene microarray analysis of lncRNA and
mRNA expression profiles in patients with hypopharyngeal squamous
cell carcinoma. Int J Clin Exp Med. 8:4862–4882. 2015.PubMed/NCBI
|
|
48
|
Zhou M, Ye Z, Gu Y, Tian B, Wu B and Li J:
Genomic analysis of drug resistant pancreatic cancer cell line by
combining long non-coding RNA and mRNA expression profling. Int J
Clin Exp Pathol. 8:38–52. 2015.PubMed/NCBI
|
|
49
|
Yang L, Zhang J, Jiang A, Liu Q, Li C,
Yang C and Xiu J: Expression profile of long non-coding RNAs is
altered in endometrial cancer. Int J Clin Exp Med. 8:5010–5021.
2015.PubMed/NCBI
|
|
50
|
Yang QQ and Deng YF: Genome-wide analysis
of long non-coding RNA in primary nasopharyngeal carcinoma by
microarray. Histopathology. 66:1022–1030. 2015. View Article : Google Scholar
|
|
51
|
Xie M, Sun M, Zhu YN, Xia R, Liu YW, Ding
J, Ma HW, He XZ, Zhang ZH, Liu ZJ, et al: Long noncoding RNA
HOXA-AS2 promotes gastric cancer proliferation by epigenetically
silencing P21/LK3/DDIT3 expression. Oncotarget. 6:33587–33601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou X, Gao Q, Wang J, Zhang X, Liu K and
Duan Z: Linc-RNA-RoR acts as a 'sponge' against mediation of the
differentiation of endometrial cancer stem cells by microRNA-145.
Gynecol Oncol. 133:333–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mattick JS and Gagen MJ: The evolution of
controlled multi-tasked gene networks: The role of introns and
other noncoding RNAs in the development of complex organisms. Mol
Biol Evol. 18:1611–1630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Popadin K, Gutierrez-Arcelus M,
Dermitzakis ET and Antonarakis SE: Genetic and epigenetic
regulation of human lincRNA gene expression. Am J Hum Genet.
93:1015–1026. 2013. View Article : Google Scholar : PubMed/NCBI
|
